These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 30400091)
41. Overexpression of glyoxalase-I reduces hyperglycemia-induced levels of advanced glycation end products and oxidative stress in diabetic rats. Brouwers O; Niessen PM; Ferreira I; Miyata T; Scheffer PG; Teerlink T; Schrauwen P; Brownlee M; Stehouwer CD; Schalkwijk CG J Biol Chem; 2011 Jan; 286(2):1374-80. PubMed ID: 21056979 [TBL] [Abstract][Full Text] [Related]
42. An overview on the role of methylglyoxal and glyoxalases in plants. Yadav SK; Singla-Pareek SL; Sopory SK Drug Metabol Drug Interact; 2008; 23(1-2):51-68. PubMed ID: 18533364 [TBL] [Abstract][Full Text] [Related]
43. Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems--role in ageing and disease. Thornalley PJ Drug Metabol Drug Interact; 2008; 23(1-2):125-50. PubMed ID: 18533367 [TBL] [Abstract][Full Text] [Related]
44. Glyoxalase I overexpression ameliorates renal ischemia-reperfusion injury in rats. Kumagai T; Nangaku M; Kojima I; Nagai R; Ingelfinger JR; Miyata T; Fujita T; Inagi R Am J Physiol Renal Physiol; 2009 Apr; 296(4):F912-21. PubMed ID: 19211689 [TBL] [Abstract][Full Text] [Related]
45. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Chen Z; Zhong C Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509 [TBL] [Abstract][Full Text] [Related]
46. Levels of Receptor for Advanced Glycation End Products and Glyoxalase-1 in the Total Circulating Extracellular Vesicles from Mild Cognitive Impairment and Different Stages of Alzheimer's Disease Patients. Haddad M; Perrotte M; Ben Khedher MR; Madec E; Lepage A; Fülöp T; Ramassamy C J Alzheimers Dis; 2021; 84(1):227-237. PubMed ID: 34487040 [TBL] [Abstract][Full Text] [Related]
47. Methylglyoxal and glyoxalase I in atherosclerosis. Hanssen NM; Stehouwer CD; Schalkwijk CG Biochem Soc Trans; 2014 Apr; 42(2):443-9. PubMed ID: 24646258 [TBL] [Abstract][Full Text] [Related]
48. Prevention of dicarbonyl-mediated advanced glycation by glyoxalases: implication in skin aging. Radjei S; Friguet B; Nizard C; Petropoulos I Biochem Soc Trans; 2014 Apr; 42(2):518-22. PubMed ID: 24646271 [TBL] [Abstract][Full Text] [Related]
49. Glyoxalase system in yeasts: structure, function, and physiology. Inoue Y; Maeta K; Nomura W Semin Cell Dev Biol; 2011 May; 22(3):278-84. PubMed ID: 21310260 [TBL] [Abstract][Full Text] [Related]
50. Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer's disease. Wong A; Lüth HJ; Deuther-Conrad W; Dukic-Stefanovic S; Gasic-Milenkovic J; Arendt T; Münch G Brain Res; 2001 Nov; 920(1-2):32-40. PubMed ID: 11716809 [TBL] [Abstract][Full Text] [Related]
51. Methylglyoxal, a Highly Reactive Dicarbonyl Compound, in Diabetes, Its Vascular Complications, and Other Age-Related Diseases. Schalkwijk CG; Stehouwer CDA Physiol Rev; 2020 Jan; 100(1):407-461. PubMed ID: 31539311 [TBL] [Abstract][Full Text] [Related]
52. Fatty acid synthase cooperates with glyoxalase 1 to protect against sugar toxicity. Garrido D; Rubin T; Poidevin M; Maroni B; Le Rouzic A; Parvy JP; Montagne J PLoS Genet; 2015 Feb; 11(2):e1004995. PubMed ID: 25692475 [TBL] [Abstract][Full Text] [Related]
53. Glyoxalase system: A systematic review of its biological activity, related-diseases, screening methods and small molecule regulators. He Y; Zhou C; Huang M; Tang C; Liu X; Yue Y; Diao Q; Zheng Z; Liu D Biomed Pharmacother; 2020 Nov; 131():110663. PubMed ID: 32858501 [TBL] [Abstract][Full Text] [Related]
54. Advanced glycation endproducts are associated with Hirano bodies in Alzheimer's disease. Münch G; Cunningham AM; Riederer P; Braak E Brain Res; 1998 Jun; 796(1-2):307-10. PubMed ID: 9689484 [TBL] [Abstract][Full Text] [Related]
55. Investigations on oxidative stress and therapeutical implications in dementia. Durany N; Münch G; Michel T; Riederer P Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 3():68-73. PubMed ID: 10654103 [TBL] [Abstract][Full Text] [Related]
56. [The role of methylglyoxal metabolism in type-2 diabetes and its complications]. Kender Z; Torzsa P; Grolmusz K V; Patócs A; Lichthammer A; Veresné Bálint M; Rácz K; Reismann P Orv Hetil; 2012 Apr; 153(15):574-85. PubMed ID: 22472358 [TBL] [Abstract][Full Text] [Related]
57. Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease. Srikanth V; Maczurek A; Phan T; Steele M; Westcott B; Juskiw D; Münch G Neurobiol Aging; 2011 May; 32(5):763-77. PubMed ID: 19464758 [TBL] [Abstract][Full Text] [Related]
58. Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine. Castellani RJ; Harris PL; Sayre LM; Fujii J; Taniguchi N; Vitek MP; Founds H; Atwood CS; Perry G; Smith MA Free Radic Biol Med; 2001 Jul; 31(2):175-80. PubMed ID: 11440829 [TBL] [Abstract][Full Text] [Related]
59. Inhibitory effect of apocynin on methylglyoxal-mediated glycation in osteoblastic MC3T3-E1 cells. Suh KS; Rhee SY; Kim YS; Choi EM J Appl Toxicol; 2015 Apr; 35(4):350-7. PubMed ID: 25042521 [TBL] [Abstract][Full Text] [Related]
60. The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases. Maessen DE; Stehouwer CD; Schalkwijk CG Clin Sci (Lond); 2015 Jun; 128(12):839-61. PubMed ID: 25818485 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]